What Researchers Did
Researchers conducted a narrative review of 25 animal and human studies to explore the potential of hyperbaric oxygen therapy (HBOT) as a treatment for various chronic pain syndromes.
What They Found
The review of 25 studies found that hyperbaric oxygen therapy (HBOT) effectively reduced pain in animal models. Early clinical research also suggests HBOT may modulate human pain, including chronic headache, fibromyalgia, complex regional pain syndrome, and trigeminal neuralgia.
What This Means for Canadian Patients
For Canadian patients experiencing chronic pain, hyperbaric oxygen therapy (HBOT) could represent a future non-pharmacological treatment option. While promising, patients should discuss current evidence and availability with their healthcare providers.
Canadian Relevance
This review was conducted by Canadian researchers, highlighting Canadian contributions to understanding hyperbaric oxygen therapy as a potential treatment for chronic pain.
Study Limitations
The researchers noted that while early clinical research is promising, further studies are needed to fully establish hyperbaric oxygen therapy's efficacy in human pain modulation.